Dicronis
PrivateLast Round
Grant
May 7, 2019
Total Funding Raised
$460,400
Company Overview
Dicronis is a medical technology company that develops minimally invasive diagnostic devices for the assessment of lymphatic function, including its flagship Lymphit platform for the early detection of lymphedema.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dicronis Comparables
Compare Dicronis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cacto Health | 86% | |
| ImpediMed Limited | 74% | |
| Boreo Oyj | 73% |
Dicronis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 7, 2019 | ||||
| Accelerator | Jan 23, 2019 | ||||
| Grant | Oct 23, 2018 | ||||
| Grant | Dec 7, 2017 | ||||
| Grant | Dec 7, 2017 | ||||
Grant | Oct 1, 2017 |
Dicronis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Boldbrain Startup Challenge | Grant |
| Merck Accelerator | Accelerator |
| ETH Zurich Foundation | Grant |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2026
Monthly visitors grew 93% MoM.
- Jan 23, 2019
$57K raised from Merck Accelerator
Dicronis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dicronis's valuation, stock price, and market status.
Is Dicronis a public or private company?
Dicronis is a private company.
What is the current stock price of Dicronis?
Dicronis is a private company with no public stock price. No recent secondary market data is available.
How much is Dicronis worth (valuation)?
Valuation information for Dicronis is not publicly available.
Can I buy Dicronis stock?
Dicronis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Dicronis's last funding round?
Dicronis's most recent funding round was Grant on May 7, 2019.
Who are the main investors in Dicronis?
Key investors in Dicronis include Horizon 2020, Merck Accelerator, ETH Zurich Foundation, Venture Kick.
Will Dicronis IPO soon?
No public IPO plans have been announced for Dicronis.
How can I track Dicronis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dicronis's secondary market activity and sign up for updates.